Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 12, 2025MedScienOpen Access

A Hypothesis for Diagnosis of Chronic Myeloid Leukemia based on miR-15a

View Full Paper
Ask AI
Bookmark
Share

Authors

RHRui HuangYYYunkun Yan

Discussion

Loading...

Member takes

Overview

Analysis identifies miR-15a and Morgana as potential biomarkers in chronic myeloid leukemia, suggesting improved diagnostic strategies.

Key Points

  • Detecting miR-15a correlates with chronic myeloid leukemia severity, enhancing diagnostic accuracy.
  • Lower levels of Morgana are associated with high miR-15a expression in chronic myeloid leukemia patients.
  • Quantitative measurement of these biomarkers in patients' samples could facilitate earlier CML diagnosis.
  • Identifying these factors may provide a clearer insight into the pathogenesis of chronic myeloid leukemia.

Cite This Study

Huang et al. (2025) studied this question.

synapsesocial.com/papers/68d44c4d31b076d99fa55ecehttps://doi.org/10.61173/1ejnkg12
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia2024 · 3 citations
  2. 2The Screening of microRNAs in Chronic Myeloid Leukemia: A Clinical Evaluation2024 · 2 citations
  3. 3miR-17-92 and miR-203A clusters as predictors of the clinical course of chronic myeloid leukemia2025
  4. 4Expression patterns of microRNAs associated with CML phases and their disease related targets2011 · 142 citations
  5. 5MicroRNA: A Signature for the Clinical Progression of Chronic Lymphocytic Leukemia2024